AAAAAA
Results:
1-12
|
Results: 12
Authors:
BRUGNATELLI S
RICCARDI A
UCCI G
PETRINI M
GIORDANO M
BARBARANO L
BERGONZI C
DEPAOLI A
CAVANNA L
ASCARI E
Citation: S. Brugnatelli et al., ORAL IDARUBICIN AND PREDNISONE FOR ADVANCED, PREVIOUSLY UNTREATED, MULTIPLE-MYELOMA - A PILOT-STUDY, Annals of oncology, 7(5), 1996, pp. 537-538
Authors:
GRIGNANI G
GOBBI PG
FORMISANO R
PIERESCA C
UCCI G
BRUGNATELLI S
RICCARDI A
ASCARI E
Citation: G. Grignani et al., A PROGNOSTIC INDEX FOR MULTIPLE-MYELOMA, British Journal of Cancer, 73(9), 1996, pp. 1101-1107
Authors:
BRUGNATELLI S
RICCARDI A
UCCI G
MORA O
BARBARANO L
PIVA N
PICCININI L
BERGONZI C
DEPAOLI A
DISTASI M
RINALDI E
TROTTI G
PETRINI M
ASCARI E
Citation: S. Brugnatelli et al., EXPERIENCE WITH POORLY MYELOSUPPRESSIVE CHEMOTHERAPY SCHEDULES FOR ADVANCED MYELOMA, British Journal of Cancer, 73(6), 1996, pp. 794-797
Authors:
RICCARDI A
GIORDANO M
BRUGNATELLI S
UCCI G
DANOVA M
MORA O
FAVA S
ASCARI E
Citation: A. Riccardi et al., ADVANCED BREAST-CANCER - A RANDOMIZED STUDY OF DIFFERENT DOSES OF EPIRUBICIN ASSOCIATED WITH FIXED DOSES OF CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL, Oncology Reports, 2(4), 1995, pp. 577-582
Authors:
RICCARDI A
GIORDANO M
BRUGNATELLI S
UCCI G
DANOVA M
MORA O
FAVA S
ASCARI E
Citation: A. Riccardi et al., DIFFERENT DOSES OF EPIRUBICIN ASSOCIATED WITH FIXED DOSES OF CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL - A RANDOMIZED STUDY IN ADVANCED BREAST-CANCER, European journal of cancer, 31A(9), 1995, pp. 1549-1551
Authors:
UCCI G
DANOVA M
RICARDI A
Citation: G. Ucci et al., OPTIMAL BONE-MARROW SAMPLE FOR CELL KINETIC-STUDIES, Cytometry, 20(3), 1995, pp. 268-268
Authors:
RICCARDI A
UCCI G
BRUGNATELLI S
MORA O
MERLINI G
PIVA N
DEPAOLI A
BARBARANO L
DISTASI M
ALBERIO F
NICOLETTI G
MORANDI S
RINALDI E
PICCININI L
ASCARI E
Citation: A. Riccardi et al., A PROSPECTIVE, CONTROLLED, NONRANDOMIZED STUDY ON PROPHYLACTIC PARENTERAL DICHLOROMETHYLENE BISPHOSPHONATE (CLODRONATE) IN MULTIPLE-MYELOMA, International journal of oncology, 5(4), 1994, pp. 833-839
Authors:
BAJETTA E
DIBARTOLOMEO M
DEBRAUD F
BOZZETTI F
BOCHICCHIO AM
COMELLA P
FAGNANI D
FARINA G
FERRONI C
FRANCHI R
GEBBIA V
IANNIELLO G
IIRILLO A
PINOTTI G
SCHIEPPATI G
UCCI G
VISINI M
ZANIBONI A
BUZZONI R
CASARTELLI C
NELLI P
Citation: E. Bajetta et al., ETOPOSIDE, DOXORUBICIN AND CISPLATIN (EAP) TREATMENT IN ADVANCED GASTRIC-CARCINOMA - A MULTICENTER STUDY OF THE ITALIAN TRIALS IN MEDICAL ONCOLOGY (ITMO) GROUP, European journal of cancer, 30A(5), 1994, pp. 596-600
Authors:
SACCHI S
LEONI P
LIBERATI M
RICCARDI A
TABILIO A
TARTONI P
MESSORA C
VECCHI A
BENSI L
RUPOLI S
UCCI G
FALZETTI F
GRIGNANI F
MARTELLI MF
Citation: S. Sacchi et al., A PROSPECTIVE COMPARISON BETWEEN TREATMENT WITH PHLEBOTOMY ALONE AND WITH INTERFERON-ALPHA IN PATIENTS WITH POLYCYTHEMIA-VERA, Annals of hematology, 68(5), 1994, pp. 247-250
Authors:
RICCARDI A
UCCI G
LUONI R
BRUGNATELLI S
MORA O
SPANEDDA R
DEPAOLI A
BARBARANO L
DISTASI M
ALBERIO F
DELFINI C
NICOLETTI G
MORANDI S
RINALDI E
PICCININI L
DEPASQUALE A
ASCARI E
Citation: A. Riccardi et al., TREATMENT OF MULTIPLE-MYELOMA ACCORDING TO THE EXTENSION OF THE DISEASE - A PROSPECTIVE, RANDOMIZED STUDY COMPARING A LESS WITH A MORE AGGRESSIVE CYTOSTATIC POLICY, British Journal of Cancer, 70(6), 1994, pp. 1203-1210
Authors:
UCCI G
RICCARDI A
LUONI R
ASCARI E
Citation: G. Ucci et al., PRESENTING FEATURES OF MONOCLONAL GAMMOPATHIES - AN ANALYSIS OF 684 NEWLY-DIAGNOSED CASES, Journal of internal medicine, 234(2), 1993, pp. 165-173
Authors:
SACCHI S
TABILIO A
LEONI P
RICCARDI A
VECCHI A
MESSORA C
BENSI L
FALZETTI F
RUPOLI S
UCCI G
MARTELLI MF
Citation: S. Sacchi et al., SUSTAINED COMPLETE HEMATOLOGICAL REMISSION IN ESSENTIAL THROMBOCYTHEMIA AFTER DISCONTINUATION OF LONG-TERM ALPHA-IFN TREATMENT, Annals of hematology, 66(5), 1993, pp. 245-246
Risultati:
1-12
|